{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T16:08:11Z","timestamp":1777651691116,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Department of Medical Mycology, Vallabhbhai Patel Chest Institute, University of Delhi"},{"DOI":"10.13039\/501100001704","name":"ESCMID","doi-asserted-by":"publisher","award":["1002"],"award-info":[{"award-number":["1002"]}],"id":[{"id":"10.13039\/501100001704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004160","name":"Mazandaran University of Medical Sciences","doi-asserted-by":"publisher","award":["2407"],"award-info":[{"award-number":["2407"]}],"id":[{"id":"10.13039\/501100004160","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.diagmicrobio.2018.03.003","type":"journal-article","created":{"date-parts":[[2018,3,8]],"date-time":"2018-03-08T18:31:17Z","timestamp":1520533877000},"page":"266-268","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["In vitro combination of voriconazole with micafungin against azole-resistant clinical isolates of Aspergillus fumigatus from different geographical regions"],"prefix":"10.1016","volume":"91","author":[{"given":"Hamed","family":"Fakhim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afsane","family":"Vaezi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Dannaoui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheshta","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bita","family":"Mousavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anuradha","family":"Chowdhary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques F.","family":"Meis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamid","family":"Badali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.diagmicrobio.2018.03.003_bb0005","doi-asserted-by":"crossref","first-page":"6916","DOI":"10.1128\/AAC.01193-16","article-title":"Potent activities of novel imidazoles lanoconazole and luliconazole against a collection of azole-resistant and -susceptible Aspergillus fumigatus strains","volume":"60","author":"Abastabar","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.diagmicrobio.2018.03.003_bb0010","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/cncr.11115","article-title":"Refractory Aspergillus pneumonia in patients with acute leukemia: successful therapy with combination caspofungin and liposomal amphotericin","volume":"97","author":"Aliff","year":"2003","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2018.03.003_bb0015","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1128\/AAC.46.1.245-247.2002","article-title":"In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp","volume":"46","author":"Arikan","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2018.03.003_bb0020","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/myc.12089","article-title":"Environmental study of azole-resistant Aspergillus fumigatus with TR34\/L98H mutations in the cyp51A gene in Iran","volume":"56","author":"Badali","year":"2013","journal-title":"Mycoses"},{"key":"10.1016\/j.diagmicrobio.2018.03.003_bb0025","doi-asserted-by":"crossref","DOI":"10.1111\/1462-2920.14055","article-title":"Emergence of azole resistant Aspergillus fumigatus and One Health: time to implement environmental stewardship","volume":"20","author":"Chowdhary","year":"2018","journal-title":"Environ Microbiol"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2018.03.003_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003633","article-title":"Emergence of azole-resistant Aspergillus fumigatus strains due to agricultural azole use creates an increasing threat to human health","volume":"9","author":"Chowdhary","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.diagmicrobio.2018.03.003_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2015.00428","article-title":"Prevalence and mechanism of triazole resistance in Aspergillus fumigatus in a referral chest hospital in Delhi, India and an update of the situation in Asia","volume":"6","author":"Chowdhary","year":"2015","journal-title":"Front Microbiol"},{"key":"10.1016\/j.diagmicrobio.2018.03.003_bb0040","series-title":"CLSI document M38\u2013A2","article-title":"Reference method for broth dilution antifungal susceptibility testing of filamentous fungi","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2008"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2018.03.003_bb0045","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1128\/AAC.49.3.1232-1235.2005","article-title":"Combined activity in vitro of caspofungin, amphotericin B, and azole agents against itraconazole-resistant clinical isolates of Aspergillus fumigatus","volume":"49","author":"Cuenca-Estrella","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2018.03.003_bb0050","doi-asserted-by":"crossref","first-page":"5157","DOI":"10.1128\/AAC.49.12.5157-5159.2005","article-title":"Effect of voriconazole combined with micafungin against Candida, Aspergillus, and Scedosporium spp. and Fusarium solani","volume":"49","author":"Heyn","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2018.03.003_bb0055","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1128\/AAC.48.3.693-715.2004","article-title":"Combination antifungal therapy","volume":"48","author":"Johnson","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.diagmicrobio.2018.03.003_bb0060","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/myc.12440","article-title":"Diagnosis and management of aspergillosis in the Netherlands: a national survey","volume":"59","author":"Lestrade","year":"2016","journal-title":"Mycoses"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2018.03.003_bb0065","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/jac\/dki343","article-title":"Micafungin in combination with voriconazole in Aspergillus species: a pharmacodynamic approach for detection of combined antifungal activity in vitro","volume":"56","author":"Lewis","year":"2005","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2018.03.003_bb0070","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1086\/423380","article-title":"Combination antifungal therapy for invasive aspergillosis","volume":"39","author":"Marr","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2018.03.003_bb0075","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7326\/M13-2508","article-title":"Combination antifungal therapy for invasive aspergillosis: a randomized trial","volume":"162","author":"Marr","year":"2015","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2018.03.003_bb0080","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/cid\/ciu581","article-title":"Antifungal combination therapy for invasive aspergillosis","volume":"59","author":"Mart\u00edn-Pe\u00f1a","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2018.03.003_bb0085","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1128\/CMR.18.1.163-194.2005","article-title":"Combination treatment of invasive fungal infections","volume":"18","author":"Mukherjee","year":"2005","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"10.1016\/j.diagmicrobio.2018.03.003_bb0090","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1099\/jmm.0.000255","article-title":"High prevalence of clinical and environmental triazole-resistant Aspergillus fumigatus in Iran: is it a challenging issue?","volume":"65","author":"Nabili","year":"2016","journal-title":"J Med Microbiol"},{"issue":"1","key":"10.1016\/j.diagmicrobio.2018.03.003_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg301","article-title":"Synergy, antagonism, and what the chequerboard puts between them","volume":"52","author":"Odds","year":"2003","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.diagmicrobio.2018.03.003_bb0105","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1128\/AAC.01572-07","article-title":"Susceptibility testing of anidulafungin and voriconazole alone and in combination against Candida and hyphae of Aspergillus spp. under hypoxic conditions","volume":"52","author":"Perkhofer","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2018.03.003_bb0110","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1128\/AAC.00045-12","article-title":"In vitro combination of anidulafungin and voriconazole against intrinsically azole-susceptible and -resistant Aspergillus spp","volume":"56","author":"Planche","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1016\/j.diagmicrobio.2018.03.003_bb0115","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1086\/339755","article-title":"Caspofungin in combination with itraconazole for the treatment of invasive aspergillosis in humans","volume":"34","author":"Rubin","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.diagmicrobio.2018.03.003_bb0120","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1128\/AAC.00980-12","article-title":"In vitro interaction of voriconazole and anidulafungin against triazole-resistant Aspergillus fumigatus","volume":"57","author":"Seyedmousavi","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"10.1016\/j.diagmicrobio.2018.03.003_bb0125","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1093\/molbev\/msr121","article-title":"MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods","volume":"28","author":"Tamura","year":"2011","journal-title":"Mol Biol Evol"},{"key":"10.1016\/j.diagmicrobio.2018.03.003_bb0130","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.drup.2015.08.001","article-title":"International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus","volume":"21-22","author":"Verweij","year":"2015","journal-title":"Drug Resist Updat"},{"issue":"3","key":"10.1016\/j.diagmicrobio.2018.03.003_bb0135","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/cid\/civ885","article-title":"Azole resistance in Aspergillus fumigatus: can we retain the clinical use of mold-active antifungal azoles?","volume":"62","author":"Verweij","year":"2016","journal-title":"Clin Infect Dis"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889318300816?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889318300816?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T12:37:21Z","timestamp":1668688641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889318300816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0732889318300816"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2018.03.003","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro combination of voriconazole with micafungin against azole-resistant clinical isolates of Aspergillus fumigatus from different geographical regions","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2018.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}